K040463

Substantially Equivalent

AESKULISA CARDIOLIPIN AGM

Applicant: Aesku, Inc.
Product code: MID
Advisory panel: Immunology
Date received: 2004-02-23
Decision date: 2004-05-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.